Table 3.

Plasma TAS, TOS, OSI, protein carbonyls (PC), 4-HNE protein adduct, oxy-LDL/MDA, 8-isoprostanes (8-isoP), and 8-OHdG of the control and streptozotocin-diabetic rats.

	TAS (μmol/mg of protein) M (min–max)	TOS (μmol/mg of protein) M (min–max)	OSI M (min–max)	PC (pmol/mg of protein) M (min–max)	4-HNE protein adduct (ng/mg of protein) M (min–max)	oxy-LDL/MDA (pg/mg of protein) M (min–max)	8-isoP (pg/mg of protein) M (min–max)	8-OHdG (pg/mg of protein) M (min–max)
C1	0.1 (0.06–0.15)	1.03 (0.32–2.44)	1.03 (0.095–1.17)	1.41 (1.07–1.48)	0.004 (0.001–0.005)	1.57 (0.99–2.64)	0.0019 (0.0018–0.0022)	0.20 (0.17–0.24)
C2	0.1 (0.05–0.16)	1.05 (0.88–1.28)	0.7 (0.47–1.13)	1.48 (1.31–2.01)	0.005 (0.001–0.007)	1.62 (1.47–2.24)	0.0018 (0.0011–0.0023)	0.21 (0.19–0.22)
DM1	0.16 (0.09–0.20)	2.84 (2.54–3.27)	1.78 (1.57–2.51)	1.57 (1.51–2.11)	6.8 (6.7–7.5)	2.29 (1.21–2.95)	0.0023 (0.0019–0.0026)	0.26 (0.24–0.30)
DM2	0.077 (0.05–0.15)	2.67 (2.48–2.74)	1.31 (1.21–1.83)	1.59 (1.09–2.19)	6.5 (6.0–7.7)	3.65 (3.08–4.01)	0.0022 (0.0017–0.0026)	0.26 (0.25–0.29)
p (C1 : C2)	ns	ns	ns	ns	ns	ns	ns	ns
p (DM1 : DM2)	ns	ns	ns	ns	ns	<0.005 (↑)	ns	ns
p (C1 : DM1)	ns	<0.0005 (↑)	<0.005 (↑)	<0.05 (↑)	<0.00005 (↑)	<0.05 (↑)	<0.05 (↑)	ns
p (C2 : DM2)	<0.05 (↓)	<0.0005 (↑)	<0.005 (↑)	<0.05 (↑)	<0.00005 (↑)	<0.005 (↑)	<0.05 (↑)	<0.05 (↑)

C1: control group in the first week of the experiment, C2: control group in the second week of the experiment, DM1: diabetic group in the first week of the experiment, DM2: diabetic group in the first second of the experiment, TAS: total antioxidant status, TOS: total oxidant status, OSI: oxidative status index, PC: protein carbonyls, 4-HNE protein adduct: 4-hydroxynonenal protein adduct, oxy-LDL/MDA: oxidized and/or MDA-modified LDL-cholesterol, 8-isoP: 8-isoprostanes, 8-OHdG: 8-hydroxy-D-guanosine, ns: not significant, p: statistical significance < 0.05, M: median, min: minimum, max: maximum, (↓): decrease, and (↑): increase.